Tactile Systems Technology, Inc. reported a 7% increase in revenue to $69.6 million, driven by a 15% increase in lymphedema product revenue. The company achieved a net income of $22.3 million, a significant improvement from the net loss of $2.3 million in the same quarter of the previous year. Improved salesforce productivity and operational efficiency contributed to record quarterly operating income and increased cash flow from operations.
Revenue increased 7% year-over-year to $69.6 million.
Lymphedema revenue increased 15% year-over-year.
Operating income was $8.0 million, compared to an operating loss of $1.6 million in the third quarter of 2022.
Net income was $22.3 million, compared to a net loss of $2.3 million in the third quarter of 2022.
The Company now expects full year 2023 total revenue in the range of $273.0 million to $277.0 million, representing growth of approximately 11% to 12% year-over-year.
Analyze how earnings announcements historically affect stock price performance